These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10383595)

  • 1. Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours.
    Miadonna A; Milazzo N; Gibelli S; Salmaso C; Lorini M; Tedeschi A
    Clin Exp Allergy; 1999 Jul; 29(7):941-9. PubMed ID: 10383595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein.
    Tedeschi A; Milazzo N; Miadonna A
    Eur Respir J; 1994 Aug; 7(8):1445-51. PubMed ID: 7525344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients.
    Horak F; Toth J; Hirschwehr R; Marks B; Stübner UP; Jäger S; Berger U; Schleinzer K; Günczler P
    Allergy; 1998 Jan; 53(1):68-72. PubMed ID: 9491231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure.
    Wang D; Clement P; Smitz J; De Waele M; Derde MP
    Int Arch Allergy Immunol; 1995 Mar; 106(3):278-85. PubMed ID: 7888790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
    Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-induced inflammation in the nose: a comparison of acute and repeated low-dose allergen exposure.
    Roquat A; Ihre E; van Hage-Hamsten M; Halldén G; Zetterström O
    Allergy; 1996 Jan; 51(1):42-8. PubMed ID: 8721527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge.
    Jacobi HH; Poulsen LK; Reimert CM; Skov PS; Ulfgren AK; Jones I; Elfman LB; Malling HJ; Mygind N
    Int Arch Allergy Immunol; 1998 May; 116(1):53-9. PubMed ID: 9623510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of slow-release theophylline on nasal antigen challenge in subjects with allergic rhinitis.
    Aubier M; Neukirch C; Maachi M; Boucara D; Engelstätter R; Steinijans V; Samoyeau R; Dehoux M
    Eur Respir J; 1998 May; 11(5):1105-10. PubMed ID: 9648963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
    de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
    Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: different degrees of responsiveness in atopic and nonatopic subjects.
    Miadonna A; Milazzo N; Lorini M; Sala A; Tedeschi A
    J Allergy Clin Immunol; 1996 Apr; 97(4):947-54. PubMed ID: 8655890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model.
    Kämpe M; Lampinen M; Stolt I; Janson C; Stålenheim G; Carlson M
    Inflammation; 2012 Feb; 35(1):230-9. PubMed ID: 21384093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intensity of early response to allergen on the late phase of both the nose and skin.
    Small P; Biskin N; Barrett D
    Ann Allergy; 1994 Sep; 73(3):252-8. PubMed ID: 8092561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis.
    Linder A; Venge P; Deuschl H
    Allergy; 1987 Nov; 42(8):583-90. PubMed ID: 2447809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
    Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ
    Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyl-aspartyl-glutamic acid inhibits cellular recruitment and mediator release during the late allergen-induced nasal reaction.
    Miadonna A; Milazzo N; Salmaso C; Cottini M; Lorini M; Tedeschi A
    Eur J Clin Pharmacol; 1998 Sep; 54(7):515-20. PubMed ID: 9832292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
    Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
    Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen.
    Assanasen P; Baroody FM; Naureckas E; Naclerio RM
    Clin Exp Allergy; 2001 Dec; 31(12):1913-22. PubMed ID: 11737044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
    Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
    Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.